| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 383.10M | 333.38M | 266.55M | 215.58M | 239.72M |
| Gross Profit | 208.92M | 175.51M | 110.54M | 69.71M | 71.91M |
| EBITDA | 80.33M | 83.42M | -34.46M | 37.97M | 20.10M |
| Net Income | 23.81M | 32.30M | -69.04M | -1.89M | -17.50M |
Balance Sheet | |||||
| Total Assets | 607.29M | 551.79M | 278.10M | 305.71M | 275.78M |
| Cash, Cash Equivalents and Short-Term Investments | 92.32M | 141.48M | 63.90M | 105.27M | 59.87M |
| Total Debt | 131.54M | 206.10M | 80.61M | 50.48M | 52.53M |
| Total Liabilities | 390.55M | 359.19M | 144.64M | 99.30M | 111.01M |
| Stockholders Equity | 215.16M | 180.87M | 123.38M | 184.91M | 141.67M |
Cash Flow | |||||
| Free Cash Flow | -965.00K | 42.36M | -13.33M | 276.00K | 15.72M |
| Operating Cash Flow | 121.19M | 42.36M | 1.30M | 15.65M | 35.59M |
| Investing Cash Flow | -115.56M | 40.16M | -8.36M | -13.65M | -18.25M |
| Financing Cash Flow | -50.02M | 12.33M | -33.38M | 50.53M | -20.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$16.20B | 9.20 | 14.29% | 5.87% | 6.88% | 11.98% | |
71 Outperform | HK$63.17B | 9.36 | 15.53% | 4.31% | 8.19% | -6.72% | |
67 Neutral | HK$2.18B | 8.34 | 8.52% | 4.00% | 3.40% | 151.24% | |
64 Neutral | HK$792.81M | 33.30 | 11.10% | ― | 14.92% | -26.47% | |
63 Neutral | HK$2.01B | 5.28 | 15.21% | 12.14% | -0.95% | 2.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$1.53B | 9.54 | 2.58% | 9.71% | -7.87% | 38.45% |